Human Immunedeficieny Virus (HIV) and pulmonary complications

Key Findings & Data:The patients have more opportunistic infections and tumors,because of the immune system supression.In early HIV disease, in which immune response is relatively pro- tected;pulmonary infections are of same agents with nor- mal population,but more offen.

💡

Conclusion & Impact:Incidence of HIV infection and its pul- monary complications are increasing in our country so that we should give more knowledge about this disease.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

More than half of HIV infected patients encounter pul- monary complications,at least once during term of their ill- ness. The patients have more opportunistic infections and tumors,because of the immune system supression.In early HIV disease, in which immune response is relatively pro- tected;pulmonary infections are of same agents with nor- mal population,but more offen. The treatment of these complications is very expensive and difficult; instead, the use of highly active antiretroviral therapy (HAART) has led to marked reduction in the incidence of the most of these complications. Incidence of HIV infection and its pul- monary complications are increasing in our country so that we should give more knowledge about this disease.

Özet

HIV pozitif hastaların yarısından fazlası hastalıklarının seyri esnasında en azından bir defa solunumsal problemle karşılaşır. Bu hastalarda HIV'e bağlı ilerleyici immün süpresyon nedeni ile fırsatçı enfeksiyonlar ve tümörler daha sık görülmektedir. İmmün cevabın rölatif olarak korunduğu erken dönem HIV enfeksiyonunda, solunumsal enfeksiyonlar ciddiyet ve etken açısından genel toplumdakine benzer ancak daha sıktır. HAART (Yüksek Aktiviteli AntiRetroviral Tedavi) nin kullanımı komplikasyon sıklığında belirgin azalma sağladığı halde bu komplikasyonların tedavileri zordur ve yüksek maliyet gerektirmektedir. Ülkemizde sıklığı gün geçtikçe artan HIV infeksiyonu ve onun akciğer komplikasyonları konusunda bilgilendirme daha sık yapılmalıdır.

🔖

Cite This Article

CHOUSEİN, U. E. G., HURŞİTOĞLU, M., ÖZVARAN, M. K. (2022). Human Immunedeficieny Virus (HIV) and pulmonary complications. Bezm-i Alem Valide Sultan SSK Vakıf Gureba Eğitim Hastanesi Derg., Cilt: 3 - Sayı: 2, 109–113. https://ajindex.com/articles/464168

References (1)

Hanley ME, Welsh CH (ed). Current Diagnosis and Treatment in Pulmonary Medicine: Segreti J., Pulmonary Complications of HIV Disease. International ed.Unýted States of America.The McGraw- Hill Comp. Inc. 2003.p 414-423 2. Miller R. HIV-associated Respiratory diseases. Lancet 1996: 348: 307-12. 3. Murphy EL, et al: Highly Active Antiretroviral Therapy Disease Mortality and Morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135:17. 4. Wolff AJ, O'Donnell AE: Pulmonary Complications of HIV infection in an era of highly active antiretroviral therapy. Chest 2001; 120:1888. 5. Fraser RS, Muller NL., Colman N, Pare PD (editors). Diagnosis of Diseases of The Chest. In: Pulmonary manifestation of Human immunodificiency virus infection. 4 th ed. Philadelphia, Pennsylvania. WB. Saunders Comp. 1999.P 1641-1697 6. British Thoracic Society Guidlines for the management of community-acquired pneumonia in adults. Thorax 2001; 56(Suppl. IV):71. 7. Macfarlane J. Guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56:Suppl.4:51-64. 8. US Public Health Service, Infectious Disease Society of America. Guidelines for the prevention of opportunistic infections in persons infected with human immunodificiency virus. MMWR 1999;48:1-66. 9. Stringer JR, Beard CB, Miller RF, et al. Anew name (Pneumocystis Jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002; 8: 81-96. 10. Kovacs JA, et al. New insights into transmission, diagnosis and drug treatment of P.Carini pneumonia. JAMA 2001; 286: 2450. 11. Miller RF, Le Noury J, et al. Pneumocystis Carini infection: Current treatment and prevention. J antimicrob Chemother 1996; 37. (Suppl. B); 35-53. 12. American Thoracic Society: Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;61:1376. 13. Joint Tuberculosis Committe of the British Thoracic Society. Chemotherapy and management of tuberculosis in the UK, recommendation: 1998. Thorax 1998; 53: 536-43.